Trials / Terminated
TerminatedNCT01953172
Health Status and Quality of Life in the Elderly
Exploratory, Double-blind, Randomized, Placebo Controlled Study of AMP-886 in the Elderly
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Unilever R&D · Industry
- Sex
- All
- Age
- 65 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The study is designed to investigate the effect of AMP886 (alpha-tocotrienol) on health status and quality of life measures, cognitive functioning, oxidative stress, inflammation markers and other symptoms effects on skin, sleep and vision in the elderly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | AMP-886 | AMP886 (alpha-tocotrienol) encapsulated in gelatin capsules |
| OTHER | Placebo | Placebo |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2013-09-30
- Last updated
- 2015-03-11
Locations
3 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT01953172. Inclusion in this directory is not an endorsement.